Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin

This publication has 11 references indexed in Scilit:

• Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1
  Clinical Microbiology and Infection, 2008
• Acinetobacter Infection
  New England Journal of Medicine, 2008
• In Vitro and In Vivo Activities of PD 0305970 and PD 0326448, New Bacterial Gyrase/Topoisomerase Inhibitors with Potent Antibacterial Activities versus Multidrug-Resistant Gram-Positive and Fastidious Organism Groups
  Antimicrobial Agents and Chemotherapy, 2007
• Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria
  International Journal of Antimicrobial Agents, 2006
• Safety of Moxifloxacin as Shown in Animal and In Vitro Studies
  Survey of Ophthalmology, 2005
• In VivoEfficacy of a New Quinolone, DQ-113, against Streptococcuspneumoniae in a MouseModel
  Antimicrobial Agents and Chemotherapy, 2003
• Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia
  Journal of Antimicrobial Chemotherapy, 2000
• Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone
  Journal of Antimicrobial Chemotherapy, 1999
• State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
  Clinical Infectious Diseases, 1998
• Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
  Journal of Antimicrobial Chemotherapy, 1997